羟氯喹治疗慢性光化性皮炎的临床效果

摘要
图/表
参考文献(15)
相关文章 (15)

全文: PDF (0 KB) HTML (33 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨羟氯喹治疗慢性光化性皮炎的临床效果。方法选取2018年8月～2019年12月沈阳市第七人民医院收治的100 例慢性光化性皮炎患者作为研究对象，按照随机信封法分为对照组（50 例）与实验组（50 例）。对照组用他可莫司软膏治疗，实验组采用羟氯喹治疗。比较两组的症状体征评分、皮肤病生活质量指数（DLQI）评分、临床治疗效果及不良反应发生情况。结果两组治疗前的症状体征评分比较，差异无统计学意义（P＞0.05）；两组治疗后的症状体征评分低于治疗前，且实验组治疗后的症状体征评分为（3.45±0.55）分，低于对照组的（5.65±0.80）分，差异均有统计学意义（P<0.05）。两组治疗前的DLQI 评分比较，差异无统计学意义（P＞0.05）；两组治疗后的DLQI 评分低于治疗前，且实验组的治疗后的DLQI 评分为（6.50±0.80）分，低于对照组的（9.55±0.90）分，差异均有统计学意义（P<0.05）。实验组的治疗总有效率为96.00%，高于对照组的80.00%，实验组的不良反应总发生率为2.00%，低于对照组的14.00%，差异有统计学意义（P<0.05）。结论慢性光化性皮炎应用羟氯喹治疗的临床效果确切，能改善相关临床症状体征，提高皮肤病患者的生活质量，且不良反应发生率低，值得临床推广。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	刘权威

关键词 ：慢性光化性皮炎, 羟氯喹, 皮肤病, 临床效果, 生活质量

Abstract：Objective To investigate the clinical effect of Hydroxychloroquine in the treatment of chronic actinic dermatitis. Methods A total of 100 patients with chronic actinic dermatitis admitted to Shenyang Seventh People′s Hospital, Liaoning Province from August 2018 to December 2019 were selected as the study objects. According to the random envelope method,they were divided into control group(50 cases)and experimental group(50 cases).The control group was treated with Tacrolimus Ointment and the experimental group was treated with Hydroxychloroquine. The symptoms and signs score,dermatology life quality index(DLQI)scale score,clinical treatment effect and adverse reactions were compared between the two groups. Results There was no significant difference the symptoms and signs score between the two groups before treatment (P＞0.05).The scores of symptoms and signs of the two groups after treatment were lower than those before treatment, the score of symptoms and signs in the experimental group was (3.45±0.55) points, lower than that in the control group of (5.65±0.80) points, the differences were statistically significant (P<0.05). There was no significant difference in DLQI score between the two groups before treatment (P＞0.05). The DLQI scores of the two groups after treatment were lower than those before treatment, the DLQI score of the experimental group was (6.50±0.80)points, lower than that of the control group of (9.55±0.90) points, the differences were statistically significant (P<0.05).The total effective rate of clinical treatment in the experimental group was 96.00%, higher than that of the control group 80.00%, the total incidence of adverse reactions in the experimental group was 2.00%, lower than that of the control group of 14.00%, the differences were statistically significant (P<0.05). Conclusion The clinical effect of Hydroxychloroquine in the treatment of chronic actinic dermatitis is accurate, it can improve the relevant clinical symptoms and signs, improve the quality of life of skin diseases, and the incidence of adverse reactions is low, it is worth clinical promotion.

Key words： Chronic actinic dermatitis Hydroxychloroquine Dermatosis Clinical effect Quality of life

引用本文:

刘权威. 羟氯喹治疗慢性光化性皮炎的临床效果[J]. 中国当代医药, 2021, 28(3): 52-54.
LIU Quan-wei. Clinical effect of Hydroxychloroquine in the treatment of chronic actinic dermatitis. 中国当代医药, 2021, 28(3): 52-54.

链接本文:

http://dangdaiyiyao.com/CN/ 或 http://dangdaiyiyao.com/CN/Y2021/V28/I3/52

[1]	邱治梅，郝进，张颖，等.桂枝茯苓丸合小柴胡汤治疗慢性光化性皮炎30 例[J].实用中医药杂志，2018，34（10）：1178-1179.
[2]	袁迎莉，李毓阳，谢志杰，等.寄生虫病妄想合并慢性光化性皮炎1 例[J].海南医学，2018，29（14）：2061-2062.
[3]	王丹旭，闵仲生.慢性光化性皮炎30 例临床分析[J].中国麻风皮肤病杂志，2017，33（12）：744-745.
[4]	江弘婧，农祥，何黎.HIV 携带者并发慢性光化性皮炎1 例[J].临床皮肤科杂志，2017，46（8）：585-587.
[5]	赵辩.中国临床皮肤病学[M].南京：江苏科学技术出版社，2010：508-512.
[6]	陈文慧，刘乐，赵玢，等.硫酸羟氯喹联合他克莫司软膏治疗慢性光化性皮炎的疗效观察[J].中国中西医结合皮肤性病学杂志，2019，18（5）：441-444.
[7]	钟安莉.羟氯喹治疗慢性光化性皮炎发生银屑病样皮损[J].中国实用医药，2016，11（30）：177-178.
[8]	吕静，江阳，刘娟娟，等.慢性光化性皮炎患者最小红斑量和T 细胞亚群检测及临床疗效观察[J].中国皮肤性病学杂志，2018，32（3）：281-286.
[9]	殷董.荨麻疹样毛囊黏蛋白病1 例[J].中华皮肤科杂志，2017，50（6）：454-455.
[10]	韩林，张志，邓晓红.槲皮素治疗慢性光化性皮炎的体外研究[J].武汉大学学报（医学版），2017，38（1）：11-14.
[11]	刘丹，田洪青.环孢素治疗慢性光化性皮炎1 例[J].中国麻风皮肤病杂志，2016，32（7）：436.
[12]	任捷，胡跃，马莉，等.慢性光化性皮炎常见致敏药物成份分析[J].世界临床药物，2019，40（9）：637-641，648.
[13]	杨成林，王敏华.慢性光化性皮炎的病因及发病机制研究进展[J].医学美学美容，2019，28（1）：198-199.
[14]	李凌佳，刘彤云.胱天蛋白酶14 在慢性光化性皮炎患者皮损中的表达及中波紫外线对其mRNA 和蛋白在Ha-CaT 细胞中表达的影响[J].中华皮肤科杂志，2019，52（7）：486-490.
[15]	李凌佳，刘彤云，何黎，等.慢性光化性皮炎173 例临床与病理分析[J].中国皮肤性病学杂志，2018，32（10）：1147-1152.